News
Earlier Announced, Aligos Therapeutics Has Been Awarded A $1.3M NIH Contract To Conduct Clinical Development Of A Compound For The Treatment Of Covid-19
1 Apr 24
Biotech, News, Contracts, General
Aligos Therapeutics Presents Clinical Data At APASL 2024 From ALG-055009 And ALG-000184 Phase 1 Studies
27 Mar 24
Biotech, News, General
12 Health Care Stocks Moving In Friday's After-Market Session
15 Mar 24
Movers
Recap: Aligos Therapeutics Q4 Earnings
12 Mar 24
Earnings
Aligos Therapeutics Q4 2023 GAAP EPS $(0.22) Beats $(0.27) Estimate, Sales $2.009M Beat $1.600M Estimate
12 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 12, 2024
12 Mar 24
Earnings
Aligos Therapeutics Earnings Preview
11 Mar 24
Earnings
Press releases
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
3 Apr 24
Press Releases
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
27 Mar 24
News, Health Care, Press Releases, General
Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024
5 Mar 24
News, Press Releases